Provided by Tiger Trade Technology Pte. Ltd.

Coherus BioSciences

1.63
-0.0003-0.02%
Volume:28.27K
Turnover:46.35K
Market Cap:243.59M
PE:1.22
High:1.64
Open:1.64
Low:1.63
Close:1.63
52wk High:2.62
52wk Low:0.7100
Shares:149.47M
Float Shares:111.19M
Volume Ratio:2.86
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.34
EPS(LYR):0.2489
ROE:331.11%
ROA:-10.26%
PB:2.78
PE(LYR):6.55

Loading ...

Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock

GlobeNewswire
·
Feb 18

BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Mohawk,

Reuters
·
Feb 14

BUZZ-U.S. STOCKS ON THE MOVE-Opus Genetics, MetaVia, Enbridge

Reuters
·
Feb 13

BUZZ-U.S. STOCKS ON THE MOVE-Silver miners, Coherus Oncology, Airbnb

Reuters
·
Feb 13

Coherus Oncology Shares Fall on $1.75 Public Offering Price

Dow Jones
·
Feb 13

BRIEF-Coherus Oncology Announces Pricing Of Public Offering Of Common Stock

Reuters
·
Feb 13

Coherus Oncology Inc - Announces Pricing of Public Offering of 28.6 Mln Shares

THOMSON REUTERS
·
Feb 13

BUZZ-Coherus Oncology tumbles on planned equity offering

Reuters
·
Feb 13

Coherus Oncology Inc - to Use Proceeds for Loqtorzi Commercialization

THOMSON REUTERS
·
Feb 13

Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock

GlobeNewswire
·
Feb 13

BRIEF-Coherus Oncology Inc - Announces Agreement With Janssen - SEC Filing

Reuters
·
Feb 04

Coherus Oncology Inc: Janssen Will Provide Pasritamig to Company, Who Will Be Sponsor of Phase 1B Clinical Trial

THOMSON REUTERS
·
Feb 04

Coherus Oncology Inc - Janssen and Co Each Retain All Commercial Rights to Their Respective Compounds

THOMSON REUTERS
·
Feb 04

Coherus Oncology startet klinische Zusammenarbeit mit Janssen zur Erforschung von mCRPC-Therapie

Reuters
·
Feb 04

Coherus Oncology (CHRS) Taps ATM Facility: Strategic Lifeline or Dilution Trade-Off for Its Pipeline?

Simply Wall St.
·
Jan 26

Oppenheimer Initiates Coverage on Coherus BioSciences With Outperform Rating

MT Newswires Live
·
Jan 23

Coherus Oncology Inc - Loqtorzi Projected to Reach $150-200M in Revenues by 2028 - SEC Filing

THOMSON REUTERS
·
Jan 13

January 2026 Penny Stock Spotlight: Three Promising Picks

Simply Wall St.
·
Jan 12

Spyglass Pharma Appoints Jean-FrÉDÉRic Viret as Chief Financial Officer

THOMSON REUTERS
·
Jan 06

Coherus Oncology Announces Positive Preclinical and Early Clinical Results for Investigational CCR8 Antibody Tagmokitug

Reuters
·
Jan 05